Merger, insolvencies and order wins shape the tape
REC-PFC merger creates ₹10Lcr giant; IVP, OSWALOR, EVOQ face existential claims; Hexaware, Alembic, Vascon score big wins
| Index | Level | Move |
|---|---|---|
| Bank Nifty | 58,291.50 | +0.61% |
| Nifty Auto | 27,353.95 | +1.36% |
| Nifty Energy | 39,481.45 | +0.77% |
| Nifty Financial Services | 29,422.60 | 0.00% |
| Nifty FMCG | 50,196.35 | +0.20% |
| Nifty Healthcare | 16,481.35 | 0.00% |
| Nifty IT | 27,276.45 | -0.59% |
| Nifty Media | 1,497.95 | -0.95% |
| Nifty Metal | 12,722.45 | +0.98% |
| Nifty Pharma | 25,866.25 | +0.47% |
| Nifty Private Bank | 16,648.10 | +2.00% |
| Nifty PSU Bank | 8,333.95 | -0.88% |
| Nifty Realty | 906.95 | +1.81% |
| Nifty Cement | 15,338.90 | 0.00% |
| Nifty Chemicals | 30,222.70 | 0.00% |
| Nifty Consumer Durables | 37,376.45 | 0.00% |
| Nifty Oil & Gas | 11,261.10 | 0.00% |
- Large-cap consolidation: REC merger with PFC creates a dominant power financier, forcing stock revaluation
- Micro-cap distress: IVP (80% mcap claim), OSWALOR (insolvency), EVOQ (insolvency) — three existential events
- Micro-cap capital events: Esaar (2.5x mcap rights issue), Esha Media (3x mcap borrowing) potential dilution bombs
- Mid/large-cap wins: Hexaware ($500M patent dismissal), Alembic (first major oncology exclusivity), PNC Infra (project completion)
- Small-cap insurance: Motisons closes ₹150cr QIP with strong appetite; Linc promoter buys ₹11cr after profit decline
- Concall credibility: Happy Square, Arabian, RMC all contradicted prior statements in same calls
REC Ltd.
REC Ltd is merging into PFC after Presidential approval, creating a power-sector financier with assets exceeding ₹10 lakh crore. For investors in both stocks, the share-exchange ratio will determine the winner. The deal forces a revaluation of the entire power-lending space on scale alone.
- ₹10 lakh crore+
- Combined assets of the proposed
- ₹96,021 cr
- Large cap mcap
- 5.89x
- P/E
- -21.69%
- PAT
- -5.02%
- Rev
- 6.33x
- D/E
IVP Ltd.
Mumbai Port Trust has ordered IVP Ltd to pay ₹136.81 crore, roughly 80% of its ₹166 crore market cap, for compensation and damages. A contingent liability that lived in footnotes is now a formal demand. The prior fraud hit of ₹6.13 crore already strained the balance sheet; this claim is existential.
- ₹136.81 cr
- Compensation and damages ordered
- ₹165 cr
- Micro cap mcap
- 8.82x
- P/E
- +131.33%
- PAT
- +10.1%
- Rev
- 0.75x
- D/E
Oswal Overseas Ltd.
Oswal Overseas, a sugar company worth ₹158 crore on market, has been pushed into insolvency over an unpaid ₹2.25 crore debt. The company failed to produce a share purchase agreement and both sides acknowledged the liability. A manageable sum became deadly because of poor documentation.
- ₹2.25 cr + interest
- Unpaid debt that triggered
- ₹156 cr
- Micro cap mcap
- -36%
- PAT
- -92.3%
- Rev
- -59.32x
- D/E
EVOQ Remedies Ltd.
Evoq Remedies enters insolvency after a creditor filed a Section 9 petition over a ₹1.95 crore advance for oil that was never delivered. The company already carries a going-concern qualification, near-zero revenue, and an SEBI probe. Insolvency formalises what the books showed for months: the business is effectively dead.
- ₹1.95 cr
- Unpaid advance that triggered the
- ₹6.08 cr
- Micro cap mcap
- 0.2%
- ROE
- 0x
- D/E
Duke Offshore Ltd.
Duke Offshore's promoters sold their 70.61% controlling stake to Aspect Global for ₹20.87 crore, a 175% premium to the company's own market cap. The new owners take control of a nano-cap whose trailing profit is shrinking. The massive premium raises the question of what they see that the market does not.
- ₹20.87 cr
- Price paid for the promoters'
- ₹23.13 cr
- Micro cap mcap
- -24.44%
- PAT
- 0.03x
- D/E
Esaar (India) Ltd.
Esaar India plans a rights issue of ₹60 crore, 2.5 times its ₹24.88 crore market cap. Rights issues of this scale relative to the company's value are rare and can either crush existing shareholders or transform the balance sheet. No rationale has been stated, making it impossible to judge intent.
- 2.5x
- Ratio of the rights-issue ceiling
- ₹25.19 cr
- Micro cap mcap
- 2.26x
- P/E
- +1216.56%
- PAT
- +751.79%
- Rev
- 1.27x
- D/E
Esha Media Research Ltd.
Esha Media Research wants to borrow ₹50 crore, 2.78 times its ₹18 crore market cap, despite a negative net worth of -₹10.4 crore and a going-concern qualification. The company also seeks ratification on past borrowing, suggesting it may have already stretched its balance sheet in secret. For a nano-cap, this is restructuring-level dilution risk.
- ₹50 cr
- Proposed borrowing limit, or 278%
- ₹19.64 cr
- Micro cap mcap
- 41.24x
- P/E
- +525.3%
- PAT
- +37.95%
- Rev
- -0.59x
- D/E
Vascon Engineers Ltd.
Vascon Engineers landed a ₹347.43 crore order from the Maharashtra government, the single largest contract in company history and worth 47% of its ₹804 crore market cap. The 36-month timeline locks in multi-year revenue from a sovereign counterparty. The core question is whether a micro-cap can execute a project this large.
- ₹347.43 cr
- Value of the single-largest order
- ₹805 cr
- Micro cap mcap
- 16.46x
- P/E
- -83.21%
- PAT
- -34.62%
- Rev
- 0.19x
- D/E
Hexaware Technologies Ltd.
Hexaware Technologies won a full dismissal of a $500 million patent infringement suit, eliminating a contingent liability equal to roughly 13.5% of its market cap. The ruling on abstract-subject-matter grounds is a strong substantive victory, not a procedural one. For a large-cap IT firm, this removes a major overhang.
- $500M
- Patent infringement claim
- ₹30,236 cr
- Large cap mcap
- 21.7x
- P/E
- +7.49%
- PAT
- +13.45%
- Rev
- 0x
- D/E
Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals secured 180-day exclusivity on a generic version of a $91 million US cancer drug, Larotrectinib. That market equals roughly 10% of Alembic's annual revenue, making it the most material single-product opportunity in its pipeline. Sole Paragraph IV status means no competition for six months post-launch.
- $91 million
- Estimated US market for generic
- ₹15,165 cr
- Mid cap mcap
- 22.47x
- P/E
- +27.42%
- PAT
- +4.41%
- Rev
- 0.23x
- D/E
PNC Infratech Ltd.
PNC Infratech completed a ₹1,413 crore hybrid annuity expressway project, worth 28% of its market cap, swapping execution risk for a steady income stream. The completion removes a major balance-sheet overhang for a mid-cap contractor with a 1.56x debt-to-equity ratio. Cash-flow predictability is the tangible gain.
- ₹1,413 cr
- Bid project cost of the completed
- ₹5,959 cr
- Mid cap mcap
- 7.16x
- P/E
- +42.84%
- PAT
- -5.11%
- Rev
- 1.56x
- D/E
Motisons Jewellers Ltd.
Motisons Jewellers closed its ₹150 crore QIP at a 4.57% discount, adding equity capital while diluting existing holders by 12.7%. The small discount signals strong institutional appetite despite a -25% PAT decline in FY26. The capital will fund expansion or debt reduction in a sector with thin margins.
- ₹150 cr
- Gross proceeds from QIP
- ₹1,607 cr
- Small cap mcap
- 25.23x
- P/E
- -25.47%
- PAT
- +15.76%
- Rev
- 0.18x
- D/E
Linc Ltd.
Linc promoter Deepak Jalan bought ₹11 crore of company stock, a 1.89% stake, after the stationary maker reported flat revenue and a 13.9% profit decline. The purchase comes amid manufacturing delays at the West Bengal plant. It is a rare insider vote of confidence after a guidance miss.
- ₹11 cr
- Approximate value of shares
- ₹687 cr
- Micro cap mcap
- 20.98x
- P/E
- -5.88%
- PAT
- -10.56%
- Rev
- 0.03x
- D/E
Gujarat Inject (Kerala) Ltd.
Gujarat Inject (Kerala) received a ₹14.49 crore solar-module order from Deon Energy, roughly 40% of its ₹36.3 crore annual revenue and its largest disclosed contract. The order follows three smaller wins in recent weeks, confirming the solar pivot is producing real revenue. The test is whether margins justify the shift.
- ₹14.49 cr
- Value of the solar-module order
- ₹180 cr
- Micro cap mcap
- 99.23x
- P/E
- +2139.73%
- PAT
- +624.52%
- Rev
- 0x
- D/E
-
Happy Square's management first blamed EBITDA compression on IPO expenses, then pivoted to AI investments when pressed. The contradiction undermines cost-transparency claims for a company guiding 80% revenue growth.
WHITEFORCE concall note -
Arabian Petroleum's CEO said a term loan was funding ₹5 crore capex, then claimed the focus was on reducing long-term debt, all in the same call. The contradiction raises credibility questions around debt management.
ARABIAN concall note -
RMC Switch slashed its Pulse Box addressable market from ₹1,40,000 crore to ₹50,000 crore and extended the execution timeline from 12 months to 2 years. Both numbers changed from the prior call, casting doubt on forecasting reliability.
RMC concall note
-
Happy Square's margin compression was initially attributed to IPO costs, but management later said heavy AI investments were the cause. The inconsistency on cost drivers, combined with 80% growth guidance, makes FY28 the credibility test.
WHITEFORCE concall note -
Arabian Petroleum's debt messaging contradicted itself within the same call: a new term loan for expansion versus a stated focus on deleveraging. Operating margins fell from 6% to 4% amid commodity inflation, and the ONGC contract win is a positive but does not fix the credibility gap.
ARABIAN concall note -
RMC Switch halved its Pulse Box total addressable market estimate and doubled the execution timeline for electrical EPC. The revisions from prior calls weaken confidence in the ₹5,000 crore FY30 aspiration.
RMC concall note -
IFB Industries' February claim that AC motor supplies to Voltas and Blue Star had 'started to go up' was contradicted in June: motors are still in trials with all sales internal. Engineering capex also missed its ₹100 crore target by 37%, and the 12 kg washing machine launch was dropped from guidance.
IFBIND concall note
- IN · CPI Inflation · prev 3.48% YoY — high-impact print for rate expectations
- IN · FX Reserves · prev $682.32 bn — liquidity check
- IN · Cargo Traffic at Major Ports · prev 2.37% YoY — economic activity proxy